コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 T-cell expression of programmed death-1 and cytotoxic T lymphocyte-associated antigen-4.
2 d-induced tumor necrosis factor receptor and cytotoxic T-lymphocyte-associated antigen-4.
3 markers, including FOXP3, CD25, Helios, and cytotoxic T lymphocyte-associated antigen 4; and impaire
4 he NKG2D pathway in the clinical activity of cytotoxic T lymphocyte-associated antigen 4 antibody blo
5 via ex vivo CD40 ligand (CD40L)/CD40 or CD28/cytotoxic T lymphocyte-associated antigen 4/B7 blockade
8 tic virus) in combination with ipilimumab (a cytotoxic T-lymphocyte-associated antigen 4 checkpoint i
9 The administration of antibodies that block cytotoxic T lymphocyte associated antigen-4 (CTLA-4) to
10 ckpoint blockade with antibodies that target cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and
11 ceptor on T lymphocytes with similarities to cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and
15 ct with the costimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) exp
18 Blockade of inhibitory signals mediated by cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) has
19 ess activation of T cells in the presence of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) imm
28 d with a CTLA-4Ig fusion protein and an anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) mon
29 in the expression of the inhibitory molecule cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) on
30 ocking inhibitory immune checkpoints such as cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) or
31 atment with monoclonal antibody specific for cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), an
32 ice and display characteristic expression of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), gl
33 tumor cell vaccines or antibody blockade of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).
34 two related cell-surface receptors, CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).
35 through CD28 and inhibitory signals through cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).
37 ing factor (GM-CSF) and antibody blockade of cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) tri
38 markers glucocorticoid-induced TNF receptor, cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), an
41 ndividuals, immunosuppression is mediated by cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and
42 tance: Checkpoint blockade therapy targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and
44 hibits an immunologic checkpoint on T cells, cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4).
45 anti-programmed cell death-1 (PD-1) or anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) ant
47 pilimumab, a monoclonal antibody that blocks cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) sig
49 ether vaccination administered together with cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) blo
51 NE study, we investigated the effects of the cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) mon
52 ly of molecules on APCs with CD28 and CD152 (cytotoxic T lymphocyte-associated antigen 4 [CTLA-4]) re
53 r T cell-associated ligands, CD28 and CD152 (cytotoxic T lymphocyte-associated antigen-4 [CTLA-4]), p
54 D-1] checkpoint inhibitor) and ipilimumab (a cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4] che
55 geted (BRAF or MEK) or an immune checkpoint (cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4] or
56 th melanoma, ipilimumab (an antibody against cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4]) pr
58 5RB, CD62L, CD103) or intracellular markers (cytotoxic T-lymphocyte-associated antigen-4, CTLA-4, and
59 A to an aptamer (apt) that selectively binds cytotoxic T lymphocyte-associated antigen 4 (CTLA4(apt))
60 include monoclonal antibodies that block the cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and
63 ponsive beige-like anchor protein (LRBA) and cytotoxic T lymphocyte-associated antigen 4 (CTLA4) defi
66 t that blockade of the coinhibitory molecule cytotoxic T lymphocyte-associated antigen 4 (CTLA4) on l
67 nuclear factor kappaB-inducing kinase (NIK), cytotoxic T lymphocyte-associated antigen 4 (CTLA4), B-c
68 ration of regulatory T cells (T(reg) cells), cytotoxic T lymphocyte-associated antigen 4 (CTLA4), int
70 remelimumab (CP-675,206), a fully human anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) mono
71 unctions by TR cells was TGFbeta, IL-10, and cytotoxic T lymphocyte-associated antigen 4 dependent.
73 as ligand, Fas, perforin, interleukin-2, and cytotoxic T-lymphocyte-associated antigen-4 exist and in
74 w costimulatory blockade agents, such as the cytotoxic T lymphocyte-associated antigen 4-Ig molecule
76 tein-1, and IL-12/IL-23 and proliferation of cytotoxic T-lymphocyte-associated antigen 4 immunoglobul
77 Abatacept (cytotoxic T-lymphocyte-associated antigen 4-immunoglobul
78 h in vitro blockade of programmed death-1 or cytotoxic T lymphocyte-associated antigen-4 increased T-
79 patients who respond to antibody-blockade of cytotoxic T lymphocyte-associated antigen 4 or vaccinati
80 dulating agents, such as antibodies blocking cytotoxic T lymphocyte-associated antigen-4 or programme
81 ath ligand (PD-L)1 pathway, not the distinct cytotoxic T lymphocyte-associated antigen 4 pathway.
82 eptors (inducible costimulator, OX40, 4-1BB, cytotoxic T lymphocyte associated antigen-4, programmed
83 variety of coinhibitory molecules, including cytotoxic T lymphocyte-associated antigen-4, programmed
84 this phase 3 study, ipilimumab--which blocks cytotoxic T-lymphocyte-associated antigen 4 to potentiat
85 atory markers FOXP3, programmed death-1, and cytotoxic T lymphocyte-associated antigen-4 was examined
86 further improved when coinhibitory receptor cytotoxic T-lymphocyte-associated antigen 4 was blocked
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。